Cardiovascular Mortality in Haemodialysis Patients Treated with Epoetin Beta – A Retrospective Study

Publisher： Karger

E-ISSN： 2235-3186|86|4|455-462

ISSN： 1660-8151

Source： Nephron, Vol.86, Iss.4, 2000-12, pp. : 455-462

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lower Serum Magnesium Is Associated with Cardiovascular Risk Factors and Mortality in Haemodialysis Patients

By  

Blood Purification, Vol. 38, Iss. 3-4, 2015-01 ,pp. : 244-252

Karger

Access to resources Recommend Favorite

A Randomized Control Study on the Procedure for Switching Epoetin Beta (EPO) to Epoetin Beta Pegol (CERA) in the Treatment of Renal Anemia in Maintenance Hemodialysis Patients

By  

Blood Purification, Vol. 38, Iss. 3-4, 2014-12 ,pp. : 174-179

Karger

Access to resources Recommend Favorite

Gender-Dependent Impact of Risk Factors for Cardiovascular and Non-Cardiovascular Mortality in End-Stage Renal Disease Patients on Haemodialysis

By  

Kidney and Blood Pressure Research, Vol. 31, Iss. 5, 2008-11 ,pp. : 360-366

Karger

Access to resources Recommend Favorite

Serum Potassium Levels and Mortality in Hemodialysis Patients: A Retrospective Cohort Study

By  

American Journal of Nephrology, Vol. 44, Iss. 3, 2016-09 ,pp. : 179-186

Karger

Access to resources Recommend Favorite

Complement and Cardiovascular Disease - The Missing Link in Haemodialysis Patients?

By  

Nephron, Vol. 134, Iss. 2, 2016-08 ,pp. : 103-103

Karger

Access to resources Recommend Favorite